论文信息 - Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren’s Syndrome? - 字舞流文

Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren’s Syndrome?

P. Dieudé | X. Mariette | L. Chiche | J. Gottenberg | J. Pers | A. Saraux | V. Devauchelle-Pensec | J. Sibilia | J. Berthelot | E. Hachulla | R. Seror | S. Jousse-Joulin | D. Cornec | J. Morel | X. Puéchal | P. Hatron | C. Larroche | C. Zarnitsky | A. Perdriger | V. Goeb | G. Hayem | J. Dubost | E. Nowak | V. le Guern | O. Vittecoq | A. Fauchais